NEMORUBICIN METABOLITE AND ANALOG REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS
    3.
    发明申请
    NEMORUBICIN METABOLITE AND ANALOG REAGENTS, ANTIBODY-DRUG CONJUGATES AND METHODS 审中-公开
    NEMORUBICIN代谢物和模拟试剂,抗体药物联合和方法

    公开(公告)号:US20140227299A1

    公开(公告)日:2014-08-14

    申请号:US14254067

    申请日:2014-04-16

    Abstract: The present invention relates to antibody-drug conjugate compounds of Formula I: Ab-(L-D)p  I where one or more nemorubicin metabolite or analog drug moieties (D) are covalently attached by a linker (L) to an antibody (Ab) which binds to one or more tumor-associated antigens or cell-surface receptors. These compounds may be useful in methods of diagnosis or treatment of cancer, and other diseases and disorders.

    Abstract translation: 本发明涉及式I的抗体 - 药物偶联化合物:Ab-(LD)p I,其中一个或多个nemorubicin代谢物或类似物药物部分(D)通过连接体(L)共价连接至抗体(Ab),其中 与一种或多种肿瘤相关抗原或细胞表面受体结合。 这些化合物可用于诊断或治疗癌症及其它疾病和病症的方法。

Patent Agency Ranking